GV and WuXi NextCode both returned to back a $68m round for DNANexus, bringing the biomedical informatics platform’s total funding to approximately $173m.

US-based medical data storage platform developer DNAnexus closed a $68m funding round yesterday featuring GV, a corporate venturing subsidiary of technology conglomerate Alphabet, and genomic information supplier WuXi NextCode. Foresite Capital, TPG Biotech and Claremont Creek Ventures and Innovatus Capital Partners also participated in the round, which included an undisclosed amount of debt financing from…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.